In this Issue
Living the Dream
By Steven D. Vold, MD
By Dana M. Blumberg, MD
By Pradeep Y. Ramulu, MD, MHS, PhD
Intravitreal injections improve visual outcomes, but the careful monitoring of patients after treatment is necessary.
By Paul Harasymowycz, MD, MSc
The latest research findings from the 22nd annual meeting of the American Glaucoma Society, held March 1 to 4, 2012, in New York City.
By Geoffrey T. Emerick, MD
When will the evidence be enough?
By Eve J. Higginbotham, SM, MD
By Ryan K. Wong, MD; Kevin Kaplowitz, MD; Inna Marcus, MD; James C. Tsai, MD; and Tomas M. Grippo, MD
Five surgeons discuss which procedure they perform first and share their tips for success.
By Garry P. Condon, MD; Thomas W. Samuelson, MD; Bradford J. Shingleton, MD; Kuldev Singh, MD, MPH; and Norman Zabriskie, MD
A higher index of suspicion for this diagnosis is warranted when the patient has predisposing risk factors for angle closure.
By Julia Song, MD
Early diagnosis and the aggressive management of elevated IOP after blunt trauma are essential.
By Quang H. Nguyen, MD
Thoughts on its diagnosis and repair.
By Robert Chang, MD
A review of the etiologies and management of elevated IOP after trauma to the crystalline lens.
By Kevin Kaplowitz, MD, and Nils Loewen, MD, PhD
Often overlooked after an injury, this serious complication is the most important limiting factor of these patients’ visual rehabilitation.
By Terri-Diann Pickering, MD
A rare complication returns.
By Sheila P. Sanders, MD
Minimize medications and dosing frequency to limit the risks to the mother, fetus, and breastfed infant.
By Pradeep Y. Ramulu, MD, MHS, PhD, and Sarwat Salim, MD
Dr. Tsai reflects on his research interests in neuroprotection, visual function, and glaucoma surgery as well as the benefits of a liberal arts education to exploring these topics.